Cargando…
Cell-Based Therapies with T Regulatory Cells
CD4(+)CD25(high)FoxP3(+) T regulatory cells (Tregs) are immunodominant suppressors in the immune system. Tregs use various mechanisms to control immune responses. Preclinical data from animal models have confirmed the huge therapeutic potential of Tregs in many immune-mediated diseases. Hence, these...
Autores principales: | Gliwiński, Mateusz, Iwaszkiewicz-Grześ, Dorota, Trzonkowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548816/ https://www.ncbi.nlm.nih.gov/pubmed/28540499 http://dx.doi.org/10.1007/s40259-017-0228-3 |
Ejemplares similares
-
Regulatory T Cells-Related Genes Are under DNA Methylation Influence
por: Piotrowska, Magdalena, et al.
Publicado: (2021) -
Therapy with CD4(+)CD25(+) T regulatory cells – should we be afraid of cancer?
por: Gliwiński, Mateusz, et al.
Publicado: (2019) -
Antigenic Challenge Influences Epigenetic Changes in Antigen-Specific T Regulatory Cells
por: Iwaszkiewicz-Grzes, Dorota, et al.
Publicado: (2021) -
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes
por: Marek-Trzonkowska, Natalia, et al.
Publicado: (2016) -
Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy
por: Gliwiński, Mateusz, et al.
Publicado: (2020)